PharmAust CEO's sayanora triggers stock plunge
Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
POK | Fully diluted market cap | 04/08/17 | 70 | 37K | |||
|
|||||||
POK | POKO converions | 10/01/17 | 66 | 28K | |||
|
|||||||
POK | up 80% on the quietest day of the yr | 30/12/15 | 0 | 1.3K | |||
|
|||||||
POK | How many shares | 30/12/15 | 174 | 78K | |||
|
|||||||
POK | What is the real potential of Buddy? | 30/12/15 | 56 | 29K | |||
|
|||||||
POK | Buddy Platform Listed | 28/12/15 | 7 | 7.8K | |||
|
|||||||
POK | The Beast | 25/12/15 | 94 | 40K | |||
|
|||||||
POK | Ann: Initial Director's Interest Notice x 3 | 24/12/15 | 22 | 11K | |||
|
See All Discussions